Expert examines secukinumab’s role in ankylosing spondylitis treatment strategies

MAUI, HAWAII – The most important development within the past year in the treatment of ankylosing spondylitis was the Food and Drug Administration approval of secukinumab (Cosentyx) as the first...
Source: Rheumatology News - Category: Rheumatology Source Type: research